Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EC HealthcareUNHLF 52 Debt-to-Equity is 0.91 as of Mar. 2026, which is 25% above its 10-year median of 0.73. GuruFocus rates UNHLF with a GF Score™ of 52/100 and a GF Value™ of $0.17. The stock has 5 warning signs investors should review. Among 564 Healthcare Providers & Services companies, EC Healthcare ranks worse than 71.28% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for EC Healthcare's Debt-to-Equity or its related term are showing as below:
UNHLF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.73 Max: 0.91
Current: 0.91
During the past 12 years, the highest Debt-to-Equity Ratio of EC Healthcare was 0.91. The lowest was 0.00. And the median was 0.73.
UNHLF's Debt-to-Equity is ranked worse than 71.28% of 564
companies
in the Healthcare Providers & Services industry
Industry Median: 0.425
vs UNHLF: 0.91
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
EC Healthcare Debt-to-Equity Related Terms
EC Healthcare Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for EC Healthcare's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, EC Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EC Healthcare Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EC Healthcare's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where EC Healthcare's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EC Healthcare (UNHLF) has a Debt-to-Equity of 0.91 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on EC Healthcare and its competitors. This is 25% above median its historical median of 0.73. According to the industry distribution chart, EC Healthcare ranks #402 out of 564 companies in the Healthcare Providers & Services industry, placing it in the top 71.3%.
Is EC Healthcare's Debt-to-Equity too high?
EC Healthcare's current Debt-to-Equity of 0.91 is 25% above median its 10-year median of 0.73. The Healthcare Providers & Services industry median Debt-to-Equity is 0.43. EC Healthcare's value of 0.91 is 114.1% above this industry median. Based on the distribution chart, EC Healthcare ranks #402 out of 564 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, EC Healthcare has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does EC Healthcare's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EC Healthcare ranks #402 out of 564 companies for Debt-to-Equity. This places EC Healthcare in the lower half of its industry. The industry median Debt-to-Equity is 0.43. EC Healthcare's value of 0.91 is 114.1% above this benchmark. While the company's 10-year median is 0.73 vs. the industry median of 0.43, EC Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.43, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EC Healthcare's current Debt-to-Equity of 0.91 is 114.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on EC Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EC Healthcare's current Debt-to-Equity is 0.91, which is 25% above median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EC Healthcare stock overvalued right now?
EC Healthcare (UNHLF) has a current Debt-to-Equity of 0.91. The stock's GF Value™ is $0.17, compared to a current price of $0.09 — trading 49.4% below its estimated fair value. The current Debt-to-Equity is 0.91, which is 25% above median its 10-year median of 0.73 and 114.1% above the Healthcare Providers & Services industry median of 0.43. EC Healthcare's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For EC Healthcare (UNHLF), the current Debt-to-Equity is 0.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EC Healthcare (UNHLF) Overvalued in 2026?
Based on GuruFocus' analysis, EC Healthcare stock appears to be undervalued.
The current stock price of $0.09 is trading 49.4% below its estimated GF Value™ of $0.17.
Key valuation signals for UNHLF:
Debt-to-Equity: 0.91 (25% above median its 10-year median of 0.73)
GF Value™: $0.17 vs. price of $0.09 (49.4% below fair value)
Industry Position: 114.1% above the Healthcare Providers & Services median (#402 of 564)
No single metric tells the full story. See the UNHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EC Healthcare is a Hong Kong-based non-hospital medical service provider. The principal activities of the group include the provision of medical services; aesthetic medical services, comprising medical aesthetics and dental services; beauty and wellness services, comprising traditional beauty, haircare, and ancillary wellness services; and the sale of skincare, healthcare, and beauty products. The group caters to its services through the operating segments of Medical, which is the key revenue generator segment and Aesthetic medical, beauty and wellness, Veterinary, and others. Geographically, the group has a business presence in Hong Kong, Macau, Mainland China, and Taiwan. It generates the majority of its revenue from Hong Kong.
52GF Score
Get the complete analysis for UNHLF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UNHLF has been successfully added to your 
